Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
HUTCHMED China Limitedtoday announces that it has voluntarily withdrawn its supplemental New Drug Application NDA in China for fruquintinib in combination with paclitaxel for the treatment of secondline advanced gastric or gastroesophageal junction a...
CancerVax Inc the developer of a breakthrough universal cancer treatment platform that will use the bodys immune system to fight cancer today announced that the Company has entered into a research agreement with Flashpoint Therapeutics to perform res...
Pierre Fabre Laboratories announced today that the European Commission EC has approved BRAFTOVI encorafenib in combination with MEKTOVI binimetinib for the treatment of adult patients with advanced nonsmall cell lung cancer
Nxera Pharma Co Ltdformerly known as Sosei Group or Sosei Heptares notes the announcement by its partner Neurocrine Biosciences Inc that NBI NBI has delivered positive topline results from its Phase clinical study in adults with schizophrenia
Bayer announced today that the first patient has been enrolled in the global Phase III SOHO trial an openlabel randomized multicenter clinical trial assessing the efficacy and safety of investigational agent BAY as firstline therapy in patients with...
Hyundai Bioscience Co Ltd currently pursuing Emergency Use Authorization EUA for its oral COVID treatment Xafty for mildtomoderate cases announced on August th that it has submitted an Investigational New Drug IND application for Phase clinical tria...
Astellas Pharma Inc today announced dosing of the first patient in the HIGHLIGHT Phase pivotal study for fezolinetant an investigational oral nonhormonal compound being studied for the treatment of moderate to severe vasomotor symptoms VMS in women...
Hilleman Laboratories has today announced that its partner Bharat Biotech has successfully launched HILLCHOL a breakthrough oral cholera vaccine OCV achieving a significant global public health milestone Singaporebased Hilleman Laboratories a joint...
Telix today announces it has submitted a New Drug Application NDA to the United States US Food and Drug Administration FDA for TLXCDx Pixclara Ffloretyrosine or FFET an investigational PET agent for the characterisation of progressive or recurrent gl...
Celltrion today announced that the European Commission EC has approved the use of SteQeyma CTP an ustekinumab biosimilar referencing Stelara for the treatment of multiple chronic inflammatory diseases
